LMMY OTC
Exousia Bio, Inc.
1W: +5.6%
1M: -48.8%
3M: -96.1%
YTD: -95.5%
1Y: -90.6%
$0.02
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
4 relationships4
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2025-11-17
Earliest Filing
2025-11-17
Latest Filing
investor: 2
target: 1
partner: 1
Counterparties (Filed by LMMY)
4 relationshipsCompanies named in LMMY's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Exousia Ai, Inc. | — | target | Target company acquired 100% by LAMY in a reorganization agreement. | 2025-11-17 | View |
| Exousia Pro Holding Management, LLC | MAJI | investor | Shareholder of Exousia Ai that received 41,223,000 Acquisition Shares. | 2025-11-17 | View |
| Progenicyte Japan CO., LTD. | — | investor | Shareholder of Exousia Ai that received 21,000,000 Acquisition Shares. | 2025-11-17 | View |
| Progenicyte | — | partner | Partnered with Exousia Ai under an Alliance Agreement for technology licensing. | 2025-11-17 | View |
Recent 8-K Filings (3)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2025-11-17 | Entry into Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Unregi | Agreement Acquisition | View |
| 2024-12-17 | Changes in Control of Registrant; Departure/Election of Directors; Appointment of Officers | View | |
| 2023-03-17 | Departure/Election of Directors; Appointment of Officers | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR